Global Phosphoinositide 3-Kinase Inhibitor Market Research Report 2022

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Pan-PI3K Inhibitors
1.2.3 Dual PI3K/mTOR inhibitors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Phosphoinositide 3-Kinase Inhibitor Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma
1.3.3 FL - Follicular Iymphoma
1.3.4 Other Indications
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Phosphoinositide 3-Kinase Inhibitor Market Perspective (2017-2028)
2.2 Phosphoinositide 3-Kinase Inhibitor Growth Trends by Region
2.2.1 Phosphoinositide 3-Kinase Inhibitor Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Phosphoinositide 3-Kinase Inhibitor Historic Market Size by Region (2017-2022)
2.2.3 Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Region (2023-2028)
2.3 Phosphoinositide 3-Kinase Inhibitor Market Dynamics
2.3.1 Phosphoinositide 3-Kinase Inhibitor Industry Trends
2.3.2 Phosphoinositide 3-Kinase Inhibitor Market Drivers
2.3.3 Phosphoinositide 3-Kinase Inhibitor Market Challenges
2.3.4 Phosphoinositide 3-Kinase Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phosphoinositide 3-Kinase Inhibitor Players by Revenue
3.1.1 Global Top Phosphoinositide 3-Kinase Inhibitor Players by Revenue (2017-2022)
3.1.2 Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Players (2017-2022)
3.2 Global Phosphoinositide 3-Kinase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phosphoinositide 3-Kinase Inhibitor Revenue
3.4 Global Phosphoinositide 3-Kinase Inhibitor Market Concentration Ratio
3.4.1 Global Phosphoinositide 3-Kinase Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphoinositide 3-Kinase Inhibitor Revenue in 2021
3.5 Phosphoinositide 3-Kinase Inhibitor Key Players Head office and Area Served
3.6 Key Players Phosphoinositide 3-Kinase Inhibitor Product Solution and Service
3.7 Date of Enter into Phosphoinositide 3-Kinase Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phosphoinositide 3-Kinase Inhibitor Breakdown Data by Type
4.1 Global Phosphoinositide 3-Kinase Inhibitor Historic Market Size by Type (2017-2022)
4.2 Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Type (2023-2028)
5 Phosphoinositide 3-Kinase Inhibitor Breakdown Data by Application
5.1 Global Phosphoinositide 3-Kinase Inhibitor Historic Market Size by Application (2017-2022)
5.2 Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
6.2 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
6.3 North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
7.2 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
7.3 Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
8.2 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
8.3 Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
9.2 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
9.3 Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size (2017-2028)
10.2 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022)
10.3 Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Phosphoinositide 3-Kinase Inhibitor Introduction
11.1.4 Bayer AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.1.5 Bayer AG Recent Development
11.2 Gilead Sciences Inc.
11.2.1 Gilead Sciences Inc. Company Detail
11.2.2 Gilead Sciences Inc. Business Overview
11.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Introduction
11.2.4 Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.2.5 Gilead Sciences Inc. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Phosphoinositide 3-Kinase Inhibitor Introduction
11.3.4 Novartis AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.3.5 Novartis AG Recent Development
11.4 TG Therapeutics Inc.
11.4.1 TG Therapeutics Inc. Company Detail
11.4.2 TG Therapeutics Inc. Business Overview
11.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Introduction
11.4.4 TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.4.5 TG Therapeutics Inc. Recent Development
11.5 Secura Bio, Inc.
11.5.1 Secura Bio, Inc. Company Detail
11.5.2 Secura Bio, Inc. Business Overview
11.5.3 Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Introduction
11.5.4 Secura Bio, Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
11.5.5 Secura Bio, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Pan-PI3K Inhibitors
Table 3. Key Players of Dual PI3K/mTOR inhibitors
Table 4. Key Players of Other
Table 5. Global Phosphoinositide 3-Kinase Inhibitor Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region (2017-2022)
Table 9. Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region (2023-2028)
Table 11. Phosphoinositide 3-Kinase Inhibitor Market Trends
Table 12. Phosphoinositide 3-Kinase Inhibitor Market Drivers
Table 13. Phosphoinositide 3-Kinase Inhibitor Market Challenges
Table 14. Phosphoinositide 3-Kinase Inhibitor Market Restraints
Table 15. Global Phosphoinositide 3-Kinase Inhibitor Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Players (2017-2022)
Table 17. Global Top Phosphoinositide 3-Kinase Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphoinositide 3-Kinase Inhibitor as of 2021)
Table 18. Ranking of Global Top Phosphoinositide 3-Kinase Inhibitor Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Phosphoinositide 3-Kinase Inhibitor Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Phosphoinositide 3-Kinase Inhibitor Product Solution and Service
Table 22. Date of Enter into Phosphoinositide 3-Kinase Inhibitor Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Type (2017-2022)
Table 26. Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Type (2023-2028)
Table 28. Global Phosphoinositide 3-Kinase Inhibitor Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Application (2017-2022)
Table 30. Global Phosphoinositide 3-Kinase Inhibitor Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Phosphoinositide 3-Kinase Inhibitor Revenue Market Share by Application (2023-2028)
Table 32. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size by Country (2023-2028) & (US$ Million)
Table 42. Bayer AG Company Detail
Table 43. Bayer AG Business Overview
Table 44. Bayer AG Phosphoinositide 3-Kinase Inhibitor Product
Table 45. Bayer AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 46. Bayer AG Recent Development
Table 47. Gilead Sciences Inc. Company Detail
Table 48. Gilead Sciences Inc. Business Overview
Table 49. Gilead Sciences Inc. Phosphoinositide 3-Kinase Inhibitor Product
Table 50. Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 51. Gilead Sciences Inc. Recent Development
Table 52. Novartis AG Company Detail
Table 53. Novartis AG Business Overview
Table 54. Novartis AG Phosphoinositide 3-Kinase Inhibitor Product
Table 55. Novartis AG Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 56. Novartis AG Recent Development
Table 57. TG Therapeutics Inc. Company Detail
Table 58. TG Therapeutics Inc. Business Overview
Table 59. TG Therapeutics Inc. Phosphoinositide 3-Kinase Inhibitor Product
Table 60. TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 61. TG Therapeutics Inc. Recent Development
Table 62. Secura Bio, Inc. Company Detail
Table 63. Secura Bio, Inc. Business Overview
Table 64. Secura Bio, Inc. Phosphoinositide 3-Kinase Inhibitor Product
Table 65. Secura Bio, Inc. Revenue in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022) & (US$ Million)
Table 66. Secura Bio, Inc. Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Type: 2021 VS 2028
Figure 2. Pan-PI3K Inhibitors Features
Figure 3. Dual PI3K/mTOR inhibitors Features
Figure 4. Other Features
Figure 5. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Application in 2021 & 2028
Figure 6. CLL/SLL - Chronic Iymphocytic Ieukemia/Small Lymphocytic Lymphoma Case Studies
Figure 7. FL - Follicular Iymphoma Case Studies
Figure 8. Other Indications Case Studies
Figure 9. Phosphoinositide 3-Kinase Inhibitor Report Years Considered
Figure 10. Global Phosphoinositide 3-Kinase Inhibitor Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Phosphoinositide 3-Kinase Inhibitor Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Region: 2021 VS 2028
Figure 13. Global Phosphoinositide 3-Kinase Inhibitor Market Share by Players in 2021
Figure 14. Global Top Phosphoinositide 3-Kinase Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phosphoinositide 3-Kinase Inhibitor as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Phosphoinositide 3-Kinase Inhibitor Revenue in 2021
Figure 16. North America Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2017-2028)
Figure 18. United States Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2017-2028)
Figure 22. Germany Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Phosphoinositide 3-Kinase Inhibitor Market Share by Region (2017-2028)
Figure 30. China Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2017-2028)
Figure 38. Mexico Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Phosphoinositide 3-Kinase Inhibitor Market Share by Country (2017-2028)
Figure 42. Turkey Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Phosphoinositide 3-Kinase Inhibitor Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Bayer AG Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 45. Gilead Sciences Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 46. Novartis AG Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 47. TG Therapeutics Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 48. Secura Bio, Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase Inhibitor Business (2017-2022)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.